Efficacy of thalidomide for refractory gastrointestinal bleeding from vascular malformation

Gastroenterology

Volumn 141, Issue 5, 2011, Pages 1629-1637.e4

  Ge, Zhi Zheng ^a,b   Chen, Hui Min ^a,b   Gao, Yun Jie ^a,b   Liu, Wen Zhong ^a,b   Xu, Chun Hong ^a,b   Tan, Hong Hong ^a,b   Chen, Hai Ying ^a,b   Wei, Wei ^a,b   Fang, Jing Yuan ^a,b   Xiao, Shu Dong ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Angiodysplasia; Angiogenesis Inhibitor; Blood Vessels; Clinical Trial; Treatment

Indexed keywords

FERROUS SUCCINATE; HEMOGLOBIN; THALIDOMIDE; VASCULOTROPIN;

ABDOMINAL DISTENSION; ADULT; AGED; ANGIODYSPLASIA; ARTICLE; BITTER TASTE; BLOOD TRANSFUSION; BLURRED VISION; BRADYCARDIA; CONGENITAL BLOOD VESSEL MALFORMATION; CONSTIPATION; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DIARRHEA; DISEASE DURATION; DIZZINESS; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG WITHDRAWAL; DRY EYE; ERYTHROCYTE TRANSFUSION; FATIGUE; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL VASCULAR MALFORMATION; HEMOGLOBIN BLOOD LEVEL; HERPES ZOSTER; HOSPITALIZATION; HUMAN; IMMUNOASSAY; IRON THERAPY; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; OCCULT BLOOD; OPEN STUDY; PARALLEL DESIGN; PARESTHESIA; PERIPHERAL EDEMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SIDE EFFECT; SOMNOLENCE; STOMACH ANTRUM VASCULAR ECTASIA; THROMBOCYTOPENIA; TINNITUS; TREATMENT RESPONSE; VAGINA DISCHARGE; VOMITING;

EID: 80054848756     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2011.07.018     Document Type: Article

References (34)

1. Regula J, Wronska E, Pachlewski J. Vascular lesions of the gastrointestinal tract. Best Pract Res Clin Gastroenterol 2008;22: 313-328. (Pubitemid 351372999)
2. Hodgson H. Hormonal therapy for gastrointestinal angiodysplasia. Lancet 2002;359:1630-1631. (Pubitemid 34518518)
3. Ell C, Remke S, May A, et al. The first prospective controlled trial comparing wireless capsule endoscopy with push enteroscopy in chronic gastrointestinal bleeding. Endoscopy 2002;34:685-689. (Pubitemid 34965667)
4. Plummer JM, Gibson TN, Mitchell DI, et al. Emergency subtotal colectomy for lower gastrointestinal haemorrhage: over-utilised or under-estimated? Int J Clin Pract 2009;63:865-868.
5. Dodda G, Trotman BW. Gastrointestinal angiodysplasia. J Assoc Acad Minor Phys 1997;8:16-19.
6. Marwick T, Kerlin P. Angiodysplasia of the upper gastrointestinal tract. Clinical spectrum in 41 cases. J Clin Gastroenterol 1986; 8:404-407. (Pubitemid 16025412)
7. Barnert J, Messmann H. Diagnosis and management of lower gastrointestinal bleeding. Nat Rev Gastroenterol Hepatol 2009;6: 637-646.
8. Di Girolamo G, Malavasi A, Cassisa L, et al. Chronic bleeding caused by small bowel angiodysplasia: a problem of recognition and diagnosis. Ital J Gastroenterol 1992;24:468-469.
9. Marshall JK, Hunt RH. Hormonal therapy for bleeding gastrointestinal mucosal vascular abnormalities. Eur J Gastroenterol Hepatol 1997;9:521-525. (Pubitemid 27214460)
10. Jarbandhan S, van der Veer WM, Mulder CJ. Double-balloon endoscopy in the diagnosis and treatment of hemorrhage from retrovalvular angiodysplasias. J Gastrointest Liver Dis 2008;17: 333-334.
11. Gady JS, Reynolds H, Blum A. Selective arterial embolization for control of lower gastrointestinal bleeding: recommendations for a clinical management pathway. Curr Surg 2003;60:344-347. (Pubitemid 36512109)
12. Brown SG, Swain CP, Storey DW, et al. Endoscopic laser treatment of vascular anomalies of the upper gastrointestinal tract. Gut 1985;26:1338-1348. (Pubitemid 16134457)
13. Junquera F, Feu F, Papo M, et al. A multicenter, randomized, clinical trial of hormonal therapy in the prevention of rebleeding from gastrointestinal angiodysplasia. Gastroenterology 2001; 121:1073-1079. (Pubitemid 33022086)
14. Junquera F, Saperas E, Videla S, et al. Long-term efficacy of octreotide in the prevention of recurrent bleeding from gastrointestinal angiodysplasia. Am J Gastroenterol 2007;102:254-260. (Pubitemid 46160536)
15. Heidt J, Langers AM, van der Meer FJ, et al. Thalidomide as treatment for digestive tract angiodysplasias. Neth J Med 2006; 64:425-428. (Pubitemid 46001912)
16. Shurafa M, Kamboj G. Thalidomide for the treatment of bleeding angiodysplasias. Am J Gastroenterol 2003;98:221-222.
17. Bauditz J, Schachschal G, Wedel S, et al. Thalidomide for treatment of severe intestinal bleeding. Gut 2004;53:609-612. (Pubitemid 38372989)
18. Kirkham SE, Lindley KJ, Elawad MA, et al. Treatment of multiple small bowel angiodysplasias causing severe life-threatening bleeding with thalidomide. J Pediatr Gastroenterol Nutr 2006;42: 585-587. (Pubitemid 43804742)
19. Dabak V, Kuriakose P, Kamboj G, et al. A pilot study of thalidomide in recurrent GI bleeding due to angiodysplasias. Dig Dis Sci 2008;53:1632-1635.
20. Dunne KA, Hill J, Dillon JF. Treatment of chronic transfusion-dependent gastric antral vascular ectasia (watermelon stomach) with thalidomide. Eur J Gastroenterol Hepatol 2006;18:455-456.
21. Kamalaporn P, Saravanan R, Cirocco M, et al. Thalidomide for the treatment of chronic gastrointestinal bleeding from angiodysplasias: a case series. Eur J Gastroenterol Hepatol 2009;21:1347-1350.
22. D'Amato RJ, Loughnan MS, Flynn E, et al. Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci U S A 1994;91: 4082-4085. (Pubitemid 24139577)
23. Junquera F, Saperas E, de Torres I, et al. Increased expression of angiogenic factors in human colonic angiodysplasia. Am J Gastroenterol 1999;94:1070-1076. (Pubitemid 29173630)
24. Rider JA, Klotz AP, Kirsner JB. Gastritis with veno-capillary ectasia as a source of massive gastric hemorrhage. Gastroenterology 1953;24:118-123.
25. Jabbari M, Cherry R, Lough JO, et al. Gastric antral vascular ectasia: the watermelon stomach. Gastroenterology 1984;87: 1165-1170. (Pubitemid 14017088)
26. Jacobson JM, Greenspan JS, Spritzler J, et al. Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. N Engl J Med 1997; 336:1487-1493. (Pubitemid 27215163)
27. Practice Guidelines for Perioperative Blood Transfusion and Adjuvant Therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 2006;105:198-208.
28. Selinger CP, Ang YS. Gastric Antral vascular ectasia: an update on clinical presentation, pathophysiology and treatment. Digestion 2008;77:131-137. (Pubitemid 351556391)
29. Richter JM, Christensen MR, Colditz GA, et al. Angiodysplasia: natural history and efficacy of therapeutic interventions. Dig Dis Sci 1989;34:1542-1546. (Pubitemid 19255345)
30. Maier SK, Hammond JM. Role of lenalidomide in the treatment of multiple myeloma and myeloysplastic syndrome. Ann Pharmacother 2006;40:286-289. (Pubitemid 43269859)
31. Richardson P, Jagannath S, Hussein M, et al. Safety and efficacy of single-agent lenalidomide in patients with relapsed and refractory multiple myeloma. Blood 2009;114:772-778.
32. Lee RJ, Springer ML, Blanco-Bose WE, et al. VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation 2000;102:898-901.
33. Franks ME, Macpherson GR, Figg WD. Thalidomide. Lancet 2004; 363:1802-1811. (Pubitemid 38698386)
34. Sharma NL, Sharma VC, Mahajan VK, et al. Thalidomide: an experience in therapeutic outcome and adverse reactions. J Dermatolog Treat 2007;18:335-340. (Pubitemid 350223205)